KEY FEATURES
| Full Name | Interferon Regulatory Factor 5 |
|---|---|
| Synonym | IRF5 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human IRF5 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human IRF5. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human IRF5 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human IRF5, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human IRF5. You can calculate the concentration of Human IRF5 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human IRF5 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.54 | 1.1 | 3.83 | 0.55 | 1.08 | 4.11 |
| Standard deviation | 0.04 | 0.06 | 0.16 | 0.03 | 0.05 | 0.2 |
| CV(%) | 6.61 | 5.39 | 4.05 | 5.15 | 4.57 | 4.86 |
RECOVERY
The recovery of Human IRF5 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 89-101 | 95 |
| EDTA plasma (n=8) | 87-100 | 92 |
| Cell culture media (n=8) | 90-105 | 97 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human IRF5 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with IRF5 ELISA Kits
| IRF3 ELISA Kit | publications with IRF5 and IRF3 |
| MYD88 ELISA Kit | publications with IRF5 and MYD88 |
| TRAF6 ELISA Kit | publications with IRF5 and TRAF6 |
| TBK1 ELISA Kit | publications with IRF5 and TBK1 |
| STAT2 ELISA Kit | publications with IRF5 and STAT2 |
| ISG15 ELISA Kit | publications with IRF5 and ISG15 |
| IRF6 ELISA Kit | publications with IRF5 and IRF6 |
Pathways associated with IRF5 ELISA Kit
| Apoptosis Pathway | Apoptosis Pathway |
| Cytokine Signaling In Immune System Pathway | Cytokine Signaling In Immune System Pathway |
| Direct P53 Effectors Pathway | Direct P53 Effectors Pathway |
| Immune System Pathway | Immune System Pathway |
| Interferon Signaling Pathway | Interferon Signaling Pathway |
| Interferon Alpha/beta Signaling Pathway | Interferon Alpha/beta Signaling Pathway |
| Interferon Gamma Signaling Pathway | Interferon Gamma Signaling Pathway |
| Regulation Of Toll-like Receptor Signaling Pathway | Regulation Of Toll-like Receptor Signaling Pathway |
| Senescence And Autophagy Pathway | Senescence And Autophagy Pathway |
| Toll-like Receptor Signaling Pathway | Toll-like Receptor Signaling Pathway |
Diseases associated with IRF5 ELISA Kit
| Lupus Erythematosus, Systemic | publications with IRF5 and Lupus Erythematosus, Systemic |
| Arthritis, Rheumatoid | publications with IRF5 and Arthritis, Rheumatoid |
| Inflammation | publications with IRF5 and Inflammation |
| Necrosis | publications with IRF5 and Necrosis |
| Scleroderma, Systemic | publications with IRF5 and Scleroderma, Systemic |
| Fibrosis | publications with IRF5 and Fibrosis |
| Liver Diseases | publications with IRF5 and Liver Diseases |
| Colitis, Ulcerative | publications with IRF5 and Colitis, Ulcerative |
| Atherosclerosis | publications with IRF5 and Atherosclerosis |
| Kidney Diseases | publications with IRF5 and Kidney Diseases |
Organs/Tissues associated with IRF5 ELISA Kit
| Blood | publications with IRF5 and Blood |
| Bone | publications with IRF5 and Bone |
| Bone Marrow | publications with IRF5 and Bone Marrow |
| Spleen | publications with IRF5 and Spleen |
| Connective Tissue | publications with IRF5 and Connective Tissue |
| Kidney | publications with IRF5 and Kidney |
| Lung | publications with IRF5 and Lung |
| Mouth | publications with IRF5 and Mouth |
| Brain | publications with IRF5 and Brain |
| Lymph Node | publications with IRF5 and Lymph Node |